Ubs Group Ag Teva Pharmaceutical Industries LTD Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $360,000 - $473,500	50,000 New	50,000 $376,000
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $1.42 Million - $1.72 Million	-168,900 Reduced 42.23%	231,100 $2.25 Million
Q2 2021 Aug 13, 2021	SELL	$9.9 - $11.56 $72,270 - $84,388	-7,300 Reduced 1.79%	400,000 $3.96 Million
Q1 2021 May 12, 2021	SELL	$10.34 - $12.81 $286,418 - $354,837	-27,700 Reduced 6.37%	407,300 $4.7 Million
Q4 2020 Feb 11, 2021	BUY	$8.61 - $11.04 $774,900 - $993,599	90,000 Added 26.09%	435,000 $4.2 Million
Q2 2020 Jul 31, 2020	SELL	$8.12 - $13.12 $6.5 Million - $10.5 Million	-800,000 Reduced 69.87%	345,000 $4.25 Million
Q1 2020 May 01, 2020	SELL	$6.69 - $13.45 $2.17 Million - $4.37 Million	-325,000 Reduced 22.11%	1,145,000 $10.3 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $4.41 Million - $7.24 Million	675,000 Added 84.91%	1,470,000 $14.4 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $123,200 - $192,000	20,000 Added 2.58%	795,000 $5.47 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $1.12 Million - $2.17 Million	138,000 Added 21.66%	775,000 $7.15 Million
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $2.92 Million - $3.75 Million	-187,200 Reduced 22.71%	637,000 $9.99 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $542,748 - $886,848	37,200 Added 4.73%	824,200 $12.7 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $13.4 Million - $16.3 Million	637,000 Added 424.67%	787,000 $17 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $3.72 Million - $5.49 Million	-222,000 Reduced 59.68%	150,000 $3.65 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $78.6 Million - $104 Million	-4,714,500 Reduced 92.69%	372,000 $6.36 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $52.1 Million - $88.5 Million	4,636,000 Added 1029.08%	5,086,500 $96.4 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $3.08 Million - $6.43 Million	199,900 Added 79.77%	450,500 $7.93 Million
Q2 2017 Aug 14, 2017	BUY	N/A	80,000 Added 46.89%	250,600 $8.33 Million
Q1 2017 Nov 14, 2017	BUY	N/A	170,600	170,600 $5.47 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$979 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$825 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$787 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$657 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$603 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account